Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 39 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Artificial intelligence (AI) is driving transformative changes in the field of medicine, with its successful application relying on accurate data and rigorous quality standards. By integrating clinical information, pathology, medical imaging, physiological signals, and omics data, AI significantly enhances the precision of research into disease mechanisms and patient prognoses. AI technologies also demonstrate exceptional potential in drug development, surgical automation, and brain-computer interface (BCI) research. Through the simulation of biological systems and prediction of intervention outcomes, AI enables researchers to rapidly translate innovations into practical clinical applications. While challenges such as computational demands, software development, and ethical considerations persist, the future of AI remains highly promising. AI plays a pivotal role in addressing societal issues like low birth rates and aging populations. AI can contribute to mitigating low birth rate issues through enhanced ovarian reserve evaluation, menopause forecasting, optimization of Assisted Reproductive Technologies (ART), sperm analysis and selection, endometrial receptivity evaluation, fertility forecasting, and remote consultations. In addressing the challenges posed by an aging population, AI can facilitate the development of dementia prediction models, cognitive health monitoring and intervention strategies, early disease screening and prediction systems, AI-driven telemedicine platforms, intelligent health monitoring systems, smart companion robots, and smart environments for aging-in-place. AI profoundly shapes the future of medicine.

Key findings

Why it matters

This general review describes how artificial intelligence is being applied across medicine, including dementia prediction models and cognitive health monitoring. It reports no tested treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 39/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 3 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 38 of the 97 points it could be judged on, which is 39 of 100. Total 39 of 100.38 of the 97 points we could judge = 39 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 38 of the 97 points we could judge it on, which is 39 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (The Innovation Medicine)
Journal's citation record 0 / 4 The Innovation Medicine: journal h-index 16 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 30 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 10.0 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 6.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 2 / 4 Cited 30 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Mei Tian: h-index 48 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 38 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 38 of the 97 points we could judge it on is 39 out of 100.
Total 39 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Dai, J., Xu, H., Chen, T., Huang, T., Liang, W., Zhang, R., et al. (2025). Artificial intelligence for medicine 2025: Navigating the endless frontier. The Innovation Medicine. https://doi.org/10.59717/j.xinn-med.2025.100120

Vancouver

Dai J, Xu H, Chen T, Huang T, Liang W, Zhang R, et al. Artificial intelligence for medicine 2025: Navigating the endless frontier. The Innovation Medicine. 2025. doi:10.59717/j.xinn-med.2025.100120.

BibTeX

@article{dai2025-ae477775,
  author  = {Dai, Jiyan and Xu, Huiyu and Chen, Tao and Huang, Tao and Liang, Weiqi and Zhang, Rui and Xu, Geng-Xin and Zhang, Zhiting and others},
  title   = {{Artificial intelligence for medicine 2025: Navigating the endless frontier}},
  journal = {The Innovation Medicine},
  year    = {2025},
  doi     = {10.59717/j.xinn-med.2025.100120},
  url     = {https://doi.org/10.59717/j.xinn-med.2025.100120}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Digital health tools

Also in Digital health tools

178 studies in the library are filed under Digital health tools with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Digital health tools hub.

Similar studies

More on Digital health tools

See all studies in Digital health tools →